Generics Must Compete On Price, Not Safety
Forbes
The FDA’s draft guidance sends the opposite message: that standards can be bent, and safety is negotiable.
Full story content is not available.
Visit Original Source
The FDA’s draft guidance sends the opposite message: that standards can be bent, and safety is negotiable.
Full story content is not available.
Visit Original Source